Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.

Show other versions (3)
Bibliographic Details
Main Authors: Rebecca C. Coll, Luke A. J. O'Neill
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3762986
id doaj-ce0a9ae541474dd3bce72d78878f8edc
record_format Article
spelling doaj-ce0a9ae541474dd3bce72d78878f8edc2020-11-25T02:00:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-018710.1371/annotation/78d328b9-2c8c-4978-84b1-7e6a0b12ada1Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.Rebecca C. CollLuke A. J. O'Neillhttp://europepmc.org/articles/PMC3762986
collection DOAJ
language English
format Article
sources DOAJ
author Rebecca C. Coll
Luke A. J. O'Neill
spellingShingle Rebecca C. Coll
Luke A. J. O'Neill
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
PLoS ONE
author_facet Rebecca C. Coll
Luke A. J. O'Neill
author_sort Rebecca C. Coll
title Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
title_short Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
title_full Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
title_fullStr Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
title_full_unstemmed Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes.
title_sort correction: the cytokine release inhibitory drug crid3 targets asc oligomerisation in the nlrp3 and aim2 inflammasomes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
url http://europepmc.org/articles/PMC3762986
work_keys_str_mv AT rebeccaccoll correctionthecytokinereleaseinhibitorydrugcrid3targetsascoligomerisationinthenlrp3andaim2inflammasomes
AT lukeajoneill correctionthecytokinereleaseinhibitorydrugcrid3targetsascoligomerisationinthenlrp3andaim2inflammasomes
_version_ 1724961798253182976

Similar Items